GLNJX | RSLDX | GLNJX / RSLDX | |
Total Expense Ratio | 2.10 | 0.80 | 263% |
Annual Report Gross Expense Ratio | 2.56 | 0.80 | 320% |
Fund Existence | 14 years | 10 years | - |
Gain YTD | 10.842 | 9.684 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 76.8M | 79.8B | 0% |
Annual Yield % from dividends | 0.00 | 0.81 | - |
Returns for 1 year | 11.40 | 10.07 | 113% |
Returns for 3 years | 29.68 | 33.39 | 89% |
Returns for 5 years | 15.87 | 20.95 | 76% |
Returns for 10 years | 47.02 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSVPX | 16.83 | 0.15 | +0.90% |
Goldman Sachs Small/Mid Cap Equity P | |||
FCDCX | 31.44 | 0.26 | +0.83% |
Fidelity Advisor Stock Selector Sm Cp C | |||
PHLCX | 12.13 | 0.06 | +0.50% |
PGIM Jennison Health Sciences C | |||
GQSCX | 13.60 | 0.04 | +0.29% |
Glenmede Disciplined US Small Cap Eq Ptf | |||
AQGNX | 12.24 | 0.02 | +0.16% |
AQR Global Equity N |